GT Biopharma Inc (GTBP)
3.05
-0.14
(-4.49%)
USD |
NASDAQ |
May 15, 16:00
3.05
0.00 (0.00%)
After-Hours: 16:18
GT Biopharma Cash from Operations (Quarterly): -2.047M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -2.047M |
| September 30, 2023 | -1.964M |
| June 30, 2023 | -1.935M |
| March 31, 2023 | -2.906M |
| December 31, 2022 | -4.298M |
| September 30, 2022 | -2.918M |
| June 30, 2022 | -2.786M |
| March 31, 2022 | -5.215M |
| December 31, 2021 | -3.705M |
| September 30, 2021 | -3.929M |
| June 30, 2021 | -4.288M |
| March 31, 2021 | -3.684M |
| December 31, 2020 | -1.927M |
| September 30, 2020 | -1.701M |
| June 30, 2020 | -3.411M |
| March 31, 2020 | -0.223M |
| December 31, 2019 | -0.485M |
| September 30, 2019 | -1.126M |
| June 30, 2019 | -1.087M |
| March 31, 2019 | -0.961M |
| December 31, 2018 | -1.244M |
| September 30, 2018 | -3.433M |
| June 30, 2018 | -1.774M |
| March 31, 2018 | -4.226M |
| December 31, 2017 | -2.152M |
| Date | Value |
|---|---|
| September 30, 2017 | -2.237M |
| June 30, 2017 | -0.391M |
| March 31, 2017 | -0.65M |
| December 31, 2016 | -0.135M |
| September 30, 2016 | -0.563M |
| June 30, 2016 | -1.065M |
| March 31, 2016 | -0.167M |
| December 31, 2015 | -0.944M |
| September 30, 2015 | -0.633M |
| June 30, 2015 | -1.293M |
| March 31, 2015 | -1.787M |
| December 31, 2014 | -1.038M |
| September 30, 2014 | -0.578M |
| June 30, 2014 | -0.043M |
| March 31, 2014 | -0.09M |
| December 31, 2013 | -0.369M |
| September 30, 2013 | 0.045M |
| June 30, 2013 | 0.02M |
| March 31, 2013 | -0.138M |
| December 31, 2012 | -0.214M |
| September 30, 2012 | -0.278M |
| June 30, 2012 | -0.303M |
| March 31, 2012 | -0.192M |
| December 31, 2011 | -0.324M |
| September 30, 2011 | -0.099M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.215M
Minimum
Mar 2022
-0.223M
Maximum
Mar 2020
-2.612M
Average
-2.786M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| Cutera Inc | -37.63M |
| Outlook Therapeutics Inc | -13.03M |
| 180 Life Sciences Corp | -2.16M |
| Journey Medical Corp | -16.52M |
| NovaBay Pharmaceuticals Inc | -1.572M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.478M |
| Free Cash Flow | -8.852M |
| Free Cash Flow Per Share (Quarterly) | -1.426 |
| Free Cash Flow Yield | -213.2% |